Linde Plc.

Linde Plc.

LIN

Get informed when a big investor buys or sells

+ Follow
Market Cap$242.2B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Linde Plc.Linde Plc.34.11.18%18%70.6

Earnings Call Q1 2026

May 1, 2026 - AI Summary

Financial Performance: Linde reported Q1 2026 EPS of $4.33, reflecting a 10% year-over-year growth. Operating margins remained robust at 30%, and return on capital stood at 24%. Sales reached $8.8 billion, an 8% increase driven by a 5% foreign currency tailwind but flat sequentially. Underlying sales saw a 3% increase attributed to 2% price hikes and 1% volume growth.
Market Segmentation and Growth: The healthcare segment grew 1% year-over-year while food & beverage surged by 5%. Electronics led the charge with a 10% growth, primarily due to investments in advanced chip manufacturing for AI. Industrial end markets showed a general recovery, with chemicals and energy growing 3% fueled by increased hydrogen and nitrogen activity in the Americas, but EMEA faced volume declines due to competitive pressures.
Challenges in EMEA: A significant challenge persists in Europe with stagnant industrial activity, especially in the chemicals sector impacted by geopolitical tensions. Volume declines were noted especially in EMEA, linked to ongoing conflicts and a shift in production to regions with competitive advantages, potentially impacting future earnings.

Exclusive for Stockcircle Pro members

Sign upSign Up
$573.00

Target Price by Analysts

9.9% upsideLinde Plc. Target Price DetailsTarget Price
$301.77

Current Fair Value

42.1% downside

Overvalued by 42.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$242.20 Billion
Enterprise Value$262.93 Billion
Dividend Yield$6.20 (1.18%)
Earnings per Share$14.67
Beta0.73
Outstanding Shares464,051,000

Return

Return on Equity18.47%ROE
Return on Assets8.25%
Return on Invested Capital13.18%

Valuation & Multiples

P/E Ratio34.1P/E Ratio
PEG310.05PEG
Price to Sales7.05Price to Sales
Price to Book Ratio6.06Price to Book Ratio
Enterprise Value to Revenue7.59
Enterprise Value to EBIT28.13
Enterprise Value to Net Income36
Total Debt to Enterprise0.09
Debt to Equity0.64Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 7, 2026
EPS Estimate
$4.27
Average shareholder expectation
Revenue Estimate
$8.59 B
Average shareholder expectation

Next Earnings Call

Expected Date
August 7, 2026
EPS Estimate
$4.48
Average shareholder expectation
Revenue Estimate
$9.00 B
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio1.3174 27.01%
Total Calls1,413,996 17.87%
Total Puts1,862,773 3.31%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %81.04% 0.40%
Total Invested$187.84B 15.25%
Investors Holding2,309 152.00%

ESG Score

No data

About Linde Plc

CEO: Stephen Angel

Relevant Senate Committees

Joint Committee on Taxation

This committee's technical expertise and official revenue estimates are critical for the development of tax legislation. Its influence directly shapes corporate tax structures and capital investment incentives, which profoundly impact Linde's financial planning, profitability, and investment decisions.

Finance

This powerful committee controls taxation and trade policy. Changes in corporate tax rates, investment credits, or international trade tariffs (e.g., impacting raw materials or global distribution) directly affect Linde's profitability, capital investment decisions, and global supply chain costs.

Appropriations

This committee directly allocates federal discretionary spending. Its subcommittees determine precise funding for defense programs, scientific research, and infrastructure projects—all areas where Linde's products and engineering services are utilized by government agencies or government contractors.

Health, Education, Labor, and Pensions

Linde supplies medical gases and related equipment, subject to FDA oversight. Furthermore, labor laws, minimum wage regulations, and union policies, which this committee oversees, directly impact Linde's operational costs and workforce management across its industrial operations.

Judiciary

As a major global corporation, Linde's strategic M&A activities are subject to antitrust review by the Department of Justice, which falls under this committee's oversight. Intellectual property protection is also crucial for Linde's advanced technologies and processes.

Armed Services

Linde supplies industrial gases and engineering solutions to defense contractors and for military applications. This committee's authorization of the annual NDAA and funding decisions for the Department of Defense directly impact a significant customer segment for Linde.

Energy and Natural Resources

Linde's operations are energy-intensive, making national energy policy and energy costs highly relevant. The company is also a key player in the emerging hydrogen economy, which falls under this committee's purview. Mining sector customers also rely on industrial gases.

Environment and Public Works

Linde's production facilities (industrial gas plants, chemical processes) are subject to stringent EPA regulations. The committee's role in driving infrastructure spending could also increase demand for industrial gases used in construction and manufacturing, and impacts regulatory costs for chemical sectors.

Foreign Relations

Linde is a global company with operations in numerous countries. U.S. foreign policy, sanctions (e.g., on energy producers or specific countries), and international trade agreements directly impact its global supply chains, market access, and operational costs.